Introduced:
May 21, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
2
Actions
26
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
May 21, 2025
Read twice and referred to the Committee on Finance.
Actions (2)
Read twice and referred to the Committee on Finance.
Type: IntroReferral
| Source: Senate
May 21, 2025
Introduced in Senate
Type: IntroReferral
| Source: Library of Congress
| Code: 10000
May 21, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (20 of 26)
(D-WA)
May 21, 2025
May 21, 2025
(D-MA)
May 21, 2025
May 21, 2025
(D-RI)
May 21, 2025
May 21, 2025
(D-VT)
May 21, 2025
May 21, 2025
(D-MD)
May 21, 2025
May 21, 2025
(D-MN)
May 21, 2025
May 21, 2025
(D-NH)
May 21, 2025
May 21, 2025
(D-RI)
May 21, 2025
May 21, 2025
(D-OR)
May 21, 2025
May 21, 2025
(D-CT)
May 21, 2025
May 21, 2025
(D-WI)
May 21, 2025
May 21, 2025
(I-ME)
May 21, 2025
May 21, 2025
(D-NY)
May 21, 2025
May 21, 2025
(D-PA)
May 21, 2025
May 21, 2025
(D-IL)
May 21, 2025
May 21, 2025
(D-IL)
May 21, 2025
May 21, 2025
(D-NV)
May 21, 2025
May 21, 2025
(D-WA)
May 21, 2025
May 21, 2025
(D-NJ)
May 21, 2025
May 21, 2025
(D-CT)
May 21, 2025
May 21, 2025
Showing latest 20 cosponsors
Full Bill Text
Length: 3,083 characters
Version: Introduced in Senate
Version Date: May 21, 2025
Last Updated: Nov 19, 2025 6:24 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 1836 Introduced in Senate
(IS) ]
<DOC>
119th CONGRESS
1st Session
S. 1836
To amend title XVIII of the Social Security Act to strengthen the drug
pricing reforms in the Inflation Reduction Act.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
May 21, 2025
Ms. Klobuchar (for herself, Mr. Welch, Ms. Smith, Mr. King, Ms.
Cantwell, Mr. Reed, Mr. Whitehouse, Ms. Duckworth, Ms. Warren, Mrs.
Gillibrand, Mr. Merkley, Mrs. Murray, Mr. Blumenthal, Mrs. Shaheen, Ms.
Cortez Masto, Ms. Baldwin, Mr. Booker, Mr. Van Hollen, Mr. Durbin, Mr.
Murphy, Mr. Fetterman, Mr. Markey, Mr. Lujan, Ms. Hassan, Mr. Heinrich,
Ms. Slotkin, and Mr. Bennet) introduced the following bill; which was
read twice and referred to the Committee on Finance
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to strengthen the drug
pricing reforms in the Inflation Reduction Act.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
[From the U.S. Government Publishing Office]
[S. 1836 Introduced in Senate
(IS) ]
<DOC>
119th CONGRESS
1st Session
S. 1836
To amend title XVIII of the Social Security Act to strengthen the drug
pricing reforms in the Inflation Reduction Act.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
May 21, 2025
Ms. Klobuchar (for herself, Mr. Welch, Ms. Smith, Mr. King, Ms.
Cantwell, Mr. Reed, Mr. Whitehouse, Ms. Duckworth, Ms. Warren, Mrs.
Gillibrand, Mr. Merkley, Mrs. Murray, Mr. Blumenthal, Mrs. Shaheen, Ms.
Cortez Masto, Ms. Baldwin, Mr. Booker, Mr. Van Hollen, Mr. Durbin, Mr.
Murphy, Mr. Fetterman, Mr. Markey, Mr. Lujan, Ms. Hassan, Mr. Heinrich,
Ms. Slotkin, and Mr. Bennet) introduced the following bill; which was
read twice and referred to the Committee on Finance
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to strengthen the drug
pricing reforms in the Inflation Reduction Act.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.
This Act may be cited as the ``Strengthening Medicare And Reducing
Taxpayer Prices Act'' or the ``SMART Prices Act''.
SEC. 2.
(a) Acceleration of the Selection of Negotiation-Eligible Drugs.--
Section 1192
(a) of the Social Security Act (42 U.
(a) of the Social Security Act (42 U.S.C. 1320f-1
(a) ) is
amended--
(1) in paragraph
(3) --
(A) by striking ``2028, 15 negotiation-eligible
drugs'' and inserting ``2028 or a subsequent year, 50
negotiation-eligible drugs''; and
(B) by striking ``; and'' at the end and inserting
a period; and
(2) by striking paragraph
(4) .
(b) Improvements to the Definition of Qualifying Single Source
Drug.--
Section 1192
(e)
(1) of the Social Security Act (42 U.
(e)
(1) of the Social Security Act (42 U.S.C. 1320f-
1
(e)
(1) ) is amended--
(1) in subparagraph
(A)
(ii) , by striking ``7 years'' and
inserting ``3 years''; and
(2) in subparagraph
(B)
(ii) , by striking ``11 years'' and
inserting ``3 years''.
(c) Improvement to the Ceiling for Maximum Fair Price.--
Section 1194
(c) (3) of the Social Security Act (42 U.
(c) (3) of the Social Security Act (42 U.S.C. 1320f-3
(c) (3) ) is
amended--
(1) in subparagraph
(A) , by striking ``75 percent'' and
inserting ``76 percent'';
(2) in subparagraph
(B) , by striking ``65 percent'' and
inserting ``55 percent''; and
(3) in subparagraph
(C) , by striking ``40 percent'' and
inserting ``30 percent''.
(d) Effective Date.--The amendments made by this section shall
apply with respect to initial price applicability years (as defined in
(c) (3) ) is
amended--
(1) in subparagraph
(A) , by striking ``75 percent'' and
inserting ``76 percent'';
(2) in subparagraph
(B) , by striking ``65 percent'' and
inserting ``55 percent''; and
(3) in subparagraph
(C) , by striking ``40 percent'' and
inserting ``30 percent''.
(d) Effective Date.--The amendments made by this section shall
apply with respect to initial price applicability years (as defined in
section 1191
(b) of the Social Security Act (42 U.
(b) of the Social Security Act (42 U.S.C. 1320f
(b) ))
beginning with initial price applicability year 2028.
<all>